Skip to content
GenoLensGenoLens

HS2ST1

Chr 1p22.3

heparan sulfate 2-O-sulfotransferase 1

Aliases:
KIAA0448
MANE:
ENST00000370550.10

Annotations refreshed 10 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • Likely inborn error of metabolism

    BIALLELIC, autosomal or pseudoautosomal
  • Skeletal dysplasia

    BIALLELIC, autosomal or pseudoautosomal
  • Undiagnosed metabolic disorders

    BIALLELIC, autosomal or pseudoautosomal
  • CAKUT

    BIALLELIC, autosomal or pseudoautosomal
  • Holoprosencephaly

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • neurofacioskeletal syndrome with or without renal agenesis

    0.71
  • Intellectual disability

    0.53
  • multiple congenital anomalies/dysmorphic syndrome-intellectual disability

    0.38
  • arthrogryposis

    0.37
  • complex neurodevelopmental disorder

    0.37
  • alcohol drinking

    0.33
  • breast benign neoplasm

    0.27
  • urolithiasis

    0.26
  • appendicitis

    0.26
  • hereditary disease

    0.19

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Heparan sulfate 2-O-sulfotransferase 1

Catalyzes the transfer of a sulfo group from 3'-phospho-5'-adenylyl sulfate (PAPS) to the 2-OH position of iduronic acid (IdoA) or glucuronic acid (GlcA) within the heparan sulfate (HS) chain and participates in HS biosynthesis (By similarity). Required for metanephric development of kidney formation, suggesting that 2-O-sulfation within HS is essential for signaling between ureteric bud and metanephric mesenchyme (By similarity)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.